arrow
B

Brian Gill

Department of Neurological Surgery
H指数:17
被引数:2,268

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Frameless stereotactic radiosurgery in the management of brain metastases: long-term oncologic and toxicity outcomes

无框架立体定向放射外科在脑转移瘤管理中的长期肿瘤学和毒性结果

2026-07-210
PRE
Convection-Enhanced Delivery of Topotecan Induces IL-1β-Associated Inflammation in Glioblastoma

拓扑替康的增强对流递送诱导胶质母细胞瘤中IL-1β相关的炎症

2026-04-010
PRE
Socioeconomic disparities in patient-reported outcomes, health literacy, and access to care among patients with primary brain tumors: findings from the All of Us Research Program

患者社会经济地位差异对原发性脑肿瘤患者报告结局、健康素养及医疗可及性的影响:美国“我们所有人”研究计划的结果

2025-12-150
PRE
HUMAN AND MOUSE PERITUMORAL SLICES DEMONSTRATE MTOR-DEPENDENT GABAERGIC NEURONAL DYSFUNCTION IN GLIOMA

人源和鼠源肿瘤周切片显示胶质瘤中存在mTOR依赖的GABA能神经元功能障碍

2025-11-010
OAAI
Intraoperative 5-Aminolevulinic Acid (5ALA) fluorescence distinguishes cellular composition and immunogenicity in the infiltrating margin of Glioblastoma

术中5-氨基乙酰丙酸(5ALA)荧光可区分胶质母细胞瘤浸润边缘的细胞组成和免疫原性。

2025-11-010
OAAI
PROMINENT GLIOMA CALCIUM TRANSIENTS CAN BE REPEATEDLY TRIGGERED BY STIMULUS-EVOKED NEURONAL ACTIVITY AND PURINERGIC SIGNALING

显著胶质瘤钙瞬变可被刺激诱发的神经元活动和嘌呤能信号反复触发。

2025-11-010
PRE
SONOBIRD: A PHASE 3 TRIAL OF BLOOD-BRAIN-BARRIER (BBB) OPENING WITH THE SONOCLOUD-9 IN RECURRENT GLIOBLASTOMA PATIENTS RECEIVING IV CARBOPLATIN

SONOBIRD:一项使用SONOCLOUD-9实现血脑屏障(BBB)开放的第3期临床试验,研究对象为接受静脉注射卡铂治疗的复发性胶质母细胞瘤患者

2025-11-010
OAAI
Single-cell analysis of drug perturbations in IDH-mutant glioma

IDH突变型胶质瘤中药物扰动作用的单细胞分析

2025-11-010
OAAI
IDH1(R132H) inhibitors enhance the sensitivity of IDH1-mutant glioma to cysteine deprivation and ferroptosis

IDH1(R132H)抑制剂增强了IDH1突变型胶质瘤对半胱氨酸剥夺和铁死亡的敏感性。

2025-11-010
OAAI
A selective small-molecule agonist of G protein-gated inwardly-rectifying potassium channels reduces epileptiform activity in mouse models of tumor-associated and provoked seizures

G蛋白门控内向整流钾通道的选择性小分子激动剂可降低肿瘤相关性和诱发性癫痫样活动的小鼠模型中的癫痫样活动

2025-03-010
PRE
Glioma-induced alterations in excitatory neurons are reversed by mTOR inhibition

胶质瘤诱导的兴奋性神经元改变可通过mTOR抑制得到逆转

NEURON
IF15
2025-01-010
PRE
EARLY SAFETY DATA FROM A RANDOMIZED, MULTICENTER, DOUBLE-BLIND, PHASE 2B STUDY OF IGV-001, AN AUTOLOGOUS CELL IMMUNOTHERAPY, VERSUS PLACEBO, IN NEWLY DIAGNOSED GLIOBLASTOMA (NDGBM)
2024-11-110
PRE
CHEMOTHERAPY INDUCED IMMUNOGENIC RESPONSE IN GLIOMA AND IMPLICATIONS FOR THERAPEUTIC STRATEGIES
2024-11-110
PRE
Autologous cell immunotherapy (IGV-001) with IGF-1R antisense oligonucleotide in newly diagnosed glioblastoma patients
2023-12-078
OA